Cubist Pharmaceuticals Inc.

$CBST - Nasdaq - Pharmaceuticals and Biotechnology
0 LAST
0 CHANGE $
0 CHANGE %
loader
ON 2
WATCHLISTS

COMMUNIQUÉ DETAILS

Up 0 0 Down
Cubist to Present at December Investor Conference

LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23rd Annual Healthcare Conference in December 2012. Details are below.

      PRESENTER:     Steve Gilman, EVP and Chief Scientific Officer
EVENT: Oppenheimer 23rd Annual Healthcare Conference
DATE: Thursday, December 13, 2012
TIME: 10:35 a.m. Eastern Time
LOCATION: The Waldorf Astoria, New York City
WEBCAST:

Live audio with slide webcast can be accessed here.

 

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.

Investors:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
Media:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com

Source: Cubist Pharmaceuticals, Inc.

SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: http://bdvt.co/Eye

SIGN IN TO BOARDVOTE

FORGOT PASSWORD?